Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
Cast:
Joel Topf
Swapnil Hiremath
Samira Farouk
Jennie Lin
Jordy Cohen
Show Notes:
55th ERS-EDTA Congress, late breaking and high impact trials. June 2018
The CJASN Review recommended by Jennie
C5a antagonist, Avacopan in ANCA-Associated Vasculitis
The fragility index as described in JAMA Surgery
Michael Walsh looks at the Fragility Index in 399 trials in medical literature
The EVOLVE trial of Cinacalcet. Age-adjusted HR results in statistically significant results for primary outcome, but was not defined as the primary endpoint. Patients were one year older in the cinacalcet group; older age known to increase mortality in dialysis patients. Wiki Journal Club.
Ron Falk and his irresponsible editorial.
NephMadness is now in full swing at the AJKDblog!
Remember Everything You Learn from Podcasts
